Evidence map›Paper›PMID 30069224›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

Suppressive Effect of Quercetin on Nitric Oxide Production from Nasal Epithelial Cells

Nachi Ebihara, Kana Takahashi, Haruka Takemura, Yuko Akanuma, Kazuhito Asano, Masataka Sunagawa

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Antioxidants (Basel, Switzerland) · 2022
    Article
  10. Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Review
  13. Evidence-based complementary and alternative medicine : eCAM · 2021
    Article
  14. Article
  15. Article
  16. Quercetin with the potential effect on allergic diseases.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nachi EbiharaDepartment of Physiology, School of Medicine, Showa University, Tokyo, Japan.
Kana TakahashiDepartment of Physiology, School of Medicine, Showa University, Tokyo, Japan.
Haruka TakemuraDepartment of Physiology, School of Medicine, Showa University, Tokyo, Japan.
Yuko AkanumaDepartment of Physiology, School of Medicine, Showa University, Tokyo, Japan.
Kazuhito AsanoDivision of Physiology, School of Nursing and Rehabilitation Sciences, Showa University, Yokohama, Japan.ORCID 0000-0001-5168-472X
Masataka SunagawaDepartment of Physiology, School of Medicine, Showa University, Tokyo, Japan.ORCID 0000-0001-7621-2024
Showa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nitric oxide (NO) is known to play pivotal roles as one of the final effector molecules in the development of allergic diseases, including allergic rhinitis (AR). Although quercetin has been reported to attenuate the clinical conditions of AR, its influence on NO production is not well defined. The present study aimed to examine the influence of quercetin on

Identifiers

PMID30069224
PMCPMC6057307
OpenAlexW2822507005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.